Tolazoline Hydrochloride

็›้…ธๅฆฅๆ‹‰ๅ”‘ๆž—

Report date: 2023/02/25 19:26:02
NME

Base Information

Drug NameTolazoline Hydrochloride
Drug Alias Name็›้…ธๆ‰˜ๆ‹‰ไฝๆž—tolazolinetolazolinum็›้…ธ-2-่‹„ๅŸบ-4๏ผŒ5-ๅ’ชๅ”‘ๅ•‰tolazolina +[7]ย 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-2a adrenergic receptor antagonistsAlpha-1a adrenergic receptor antagonists
TargetsAlpha-2a adrenergic receptorAlpha-1a adrenergic receptor
Therapy Area/IndicationsPulmonary Arterial HypertensionPersistent Fetal Circulation Syndrome
Global Approved IndicationsPulmonary Arterial Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1948/03/17
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Xudong Haipu Pharmaceutical Co Ltd
Inactive CompaniesNovartis Pharma Ag
Active IndicationsPersistent Fetal Circulation Syndrome
Inactive IndicationsPulmonary Arterial Hypertension

Other Information

ATC CodeC04AB02M02AX02
Related LinksWikipediaDrugBankKEGG